Vertex Pharmaceuticals Inc (VRTX) Ownership & Trading Activity

Institutional holders, insider transactions, and congressional trades for VRTX. 13F holdings as of 2026-06-30.

In 13F filings for the quarter ended June 30, 2026, 1,722 institutions reported holding VRTX, with 239.6 million shares worth $118.8 billion in aggregate.

Top Institutional Holders

InstitutionSharesValueChange
Capital Group50,340,548$25.0BDECREASED
BlackRock24,109,373$12.0BINCREASED
Vanguard24,100,823$12.0BDECREASED
State Street11,871,459$5.9BINCREASED
Invesco Ltd8,043,052$4.0BINCREASED

Recent Insider Trades

InsiderTypeSharesValueDate
Daniel J. Brennan (Director)AWARD795$400K2026-10-20
Bruce I Sachs (Director)AWARD92$48K2026-10-15
Alan M Garber (Director)AWARD29$15K2026-10-15
Jasper Van Grunsven (EVP, CP and NPPO)AWARD8,6822026-09-08
Kristen Ambrose (SVP & Chief Accounting Officer)AWARD5,0002026-08-28

Recent Congressional Trades

MemberTypeAmountDate
Ro Khanna (Democrat)PURCHASE$1,001 - $15,0002026-09-04
David J. Taylor (Republican)SALE$1,001 - $15,0002026-08-26
David J. Taylor (Republican)SALE$1,001 - $15,0002026-08-25

Full institutional holdings, insider history, and congressional trades for Vertex Pharmaceuticals Inc on SentiSense.